You are here: Industry Insights > Novavax

News List

Novavax Makes Leadership Changes contractpharma
November 12, 2020
Novavax Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has updated its leadership team and appointed Gregory F. Covino as executive vice president and chief financial officer (CFO).
1600 participants enrolled for Phase III clinical trials of Covishield expresspharma
November 12, 2020
SII and ICMR are conducting Phase 2/3 clinical trial of COVISHIELD at 15 different centres, across the country.
Novavax COVID-19 vaccine granted Fast Track Designation by U.S. FDA worldpharmanews
November 11, 2020
Novavax, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.
Novavax Expands Facility to Support Global Vaccine Development contractpharma
November 11, 2020
Expands campus with two properties to support vaccine research and development, manufacturing, business operations.
Australia to acquire 40 million doses of Novavax Covid-19 vaccine pharmaceutical-technology
November 06, 2020
Novavax has signed a non-binding heads of terms document with the Australian Government to supply 40 million doses of its Covid-19 vaccine candidate, NVX-CoV2373.
Novavax provides Phase 3 COVID-19 vaccine clinical development update worldpharmanews
October 29, 2020
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate.
Serum Institute of India: outsourced manufacturing of COVID-19 vaccines europeanpharmaceuticalreview
September 27, 2020
As the COVID-19 pandemic and the search for an effective preventative vaccine continues, the Serum Institute of India has entered into manufacturing agreements with both Novavax and Codagenix to help supply their experimental COVID-19 vaccine candidates.
Novavax, Par Sterile Products Enter COVID-19 Vax Mfg. Pact contractpharma
September 27, 2020
Par Sterile's Rochester facility began production of NVX-CoV2373 final drug product, with initial batches to be used in Novavax' Phase III trial.
Novavax begins late-stage trial of COVID-19 vaccine in the UK expresspharma
September 27, 2020
Data from the trial - likely over the next four to six weeks - will support regulatory submissions for license in the UK, EU and other countries.
Novavax expands deal with Serum Institute, aims for two billion COVID-19 vaccine doses expresspharma
September 16, 2020
Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page